Mink Therapeutics Inc (INKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 09-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,691 | 299 | N/A | N/A | N/A |
| Other current assets | 914 | 532 | 0 | 0 | 5,530 |
| TOTAL | $4,097 | $918 | $N/A | $N/A | $5,530 |
| Non-Current Assets | |||||
| PPE Net | 458 | 391 | N/A | N/A | N/A |
| Investments And Advances | 0 | 0 | 0 | 0 | 330 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 20,530 |
| TOTAL | $458 | $391 | $N/A | $N/A | $20,860 |
| Total Assets | $4,555 | $1,309 | $N/A | $N/A | $26,390 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,672 | 4,627 | 0 | 0 | 10,020 |
| Accrued Expenses | 1,859 | 2,601 | N/A | N/A | 30,180 |
| Other current liabilities | 5,691 | N/A | N/A | N/A | 26,760 |
| TOTAL | $14,222 | $7,419 | $N/A | $N/A | $98,170 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 191 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 44,207 | 30,224 | 0 | 0 | 180 |
| TOTAL | $44,207 | $30,224 | $N/A | $N/A | $390 |
| Total Liabilities | $58,429 | $37,643 | $N/A | $N/A | $98,560 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 0 | N/A | N/A | 160 |
| Retained earnings | -52,735 | -36,496 | N/A | N/A | N/A |
| Other shareholders' equity | -1,523 | -133 | 0 | 0 | -3,310 |
| TOTAL | $-53,874 | $-36,334 | $N/A | $N/A | $949,450 |
| Total Liabilities And Equity | $4,555 | $1,309 | $0 | $0 | $1,048,010 |